Human Th17 Cells Comprise Heterogeneous Subsets Including IFN-γ–Producing Cells with Distinct Properties from the Th1 Lineage
暂无分享,去创建一个
T. Mcclanahan | R. Pierce | R. de Waal Malefyt | S. Sadekova | M. McGeachy | W. Blumenschein | B. Basham | B. Desai | K. Boniface | Katherine Brovont-Porth
[1] P. Rutgeerts,et al. Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double‐blind, placebo‐controlled, multiple‐dose study , 2010, Inflammatory bowel diseases.
[2] V. Kuchroo,et al. Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes1 , 2009, The Journal of Immunology.
[3] S. Durham,et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. , 2009, The Journal of clinical investigation.
[4] E. Tolosa,et al. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. , 2009, Brain : a journal of neurology.
[5] R. Bronson,et al. Encephalitogenic T cells that stably express both T-bet and RORγt consistently produce IFNγ but have a spectrum of IL-17 profiles , 2009, Journal of Neuroimmunology.
[6] Chia-Lin Wei,et al. ChIP'ing the mammalian genome: technical advances and insights into functional elements , 2009, Genome Medicine.
[7] B. Stockinger,et al. The aryl hydrocarbon receptor in immunity. , 2009, Trends in immunology.
[8] P. Duquette,et al. Preferential recruitment of interferon‐γ–expressing TH17 cells in multiple sclerosis , 2009, Annals of neurology.
[9] D. Jarrossay,et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells , 2009, Nature Immunology.
[10] H. Spits,et al. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells , 2009, Nature Immunology.
[11] Yuhong Yang,et al. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells , 2009, The Journal of experimental medicine.
[12] D. Littman,et al. Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.
[13] Gary D. Stormo,et al. The AP-1 transcription factor Batf controls TH17 differentiation , 2009, Nature.
[14] Zhihong Wu,et al. c-Maf Regulates IL-10 Expression during Th17 Polarization1 , 2009, The Journal of Immunology.
[15] T. Mcclanahan,et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling , 2009, The Journal of experimental medicine.
[16] Erin E. Murphy,et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation , 2009, The Journal of experimental medicine.
[17] D. Bending,et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. , 2009, The Journal of clinical investigation.
[18] Yuka Kanno,et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. , 2009, Immunity.
[19] C. Elson,et al. Late developmental plasticity in the T helper 17 lineage. , 2009, Immunity.
[20] Yi-hong Wang,et al. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells , 2009, European journal of immunology.
[21] B. Blom,et al. From interleukin‐23 to T‐helper 17 cells: human T‐helper cell differentiation revisited , 2008, Immunological reviews.
[22] Warren Strober,et al. Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17–producing T cells , 2008, Nature Immunology.
[23] Hyun-Dong Chang,et al. Th memory for interleukin‐17 expression is stable in vivo , 2008, European journal of immunology.
[24] L. Cosmi,et al. Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor , 2008, The Journal of experimental medicine.
[25] B. Segal,et al. IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition , 2008, The Journal of experimental medicine.
[26] Y. Iwakura,et al. Development of Proteoglycan-Induced Arthritis Is Independent of IL-171 , 2008, The Journal of Immunology.
[27] E. Wawrousek,et al. Both Th1 and Th17 Are Immunopathogenic but Differ in Other Key Biological Activities1 , 2008, The Journal of Immunology.
[28] A. Kallies. Distinct regulation of effector and memory T‐cell differentiation , 2008, Immunology and cell biology.
[29] K. Maloy. The Interleukin‐23 / Interleukin‐17 axis in intestinal inflammation , 2008, Journal of internal medicine.
[30] Y. Iwakura,et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category , 2008, The Journal of experimental medicine.
[31] E. Wawrousek,et al. Phenotype Switching by Inflammation-Inducing Polarized Th17 Cells, but Not by Th1 Cells1 , 2008, The Journal of Immunology.
[32] Jia Newcombe,et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. , 2008, The American journal of pathology.
[33] C. Hunter,et al. Negative regulation of Th17 responses. , 2007, Seminars in immunology.
[34] T. Mcclanahan,et al. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology , 2007, Nature Immunology.
[35] Nathalie Arbour,et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.
[36] C. Tato,et al. Distinct regulation of interleukin-17 in human T helper lymphocytes. , 2007, Arthritis and rheumatism.
[37] Kathleen M. Smith,et al. Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.
[38] L. Cosmi,et al. Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.
[39] F. Sallusto,et al. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells , 2007, Nature Immunology.
[40] D. Jarrossay,et al. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.
[41] A. Lovett-racke,et al. T-bet Regulates the Fate of Th1 and Th17 Lymphocytes in Autoimmunity1 , 2007, The Journal of Immunology.
[42] A. Sher,et al. IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis , 2006, The Journal of experimental medicine.
[43] L. Fouser,et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.
[44] D. Littman,et al. The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.
[45] Shailendra Giri,et al. T‐bet is essential for the progression of experimental autoimmune encephalomyelitis , 2006, Immunology.
[46] K. Murphy,et al. Th17: an effector CD4 T cell lineage with regulatory T cell ties. , 2006, Immunity.
[47] T. Mcclanahan,et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.
[48] L. Presta,et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. , 2006, The Journal of clinical investigation.
[49] R. Kastelein,et al. Understanding the IL-23-IL-17 immune pathway. , 2006, Trends in immunology.
[50] A. Gurney,et al. IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes1 , 2005, The Journal of Immunology.
[51] T. Mcclanahan,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.
[52] K. Asadullah,et al. IL-22 increases the innate immunity of tissues. , 2004, Immunity.
[53] S. Szabo,et al. Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis , 2004, The Journal of experimental medicine.
[54] T. Mcclanahan,et al. Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.
[55] A. Gurney,et al. Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.
[56] K. Mikecz,et al. IL-4 and IL-12 Regulate Proteoglycan-Induced Arthritis Through Stat-Dependent Mechanisms1 , 2002, The Journal of Immunology.
[57] M. Byrne,et al. Microbial Lipopeptides Induce the Production of IL-17 in Th Cells1 , 2000, The Journal of Immunology.
[58] Laurie H Glimcher,et al. A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment , 2000, Cell.
[59] W. Fanslow,et al. Human IL-17: a novel cytokine derived from T cells. , 1995, Journal of immunology.
[60] F. Denizot,et al. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. , 1993, Journal of immunology.